Apollo Hospitals Enterprise Limited: Scheme of Arrangement filed with NCLT
Apollo Hospitals Enterprise Limited filed a Scheme of Arrangement and formally notified the National Stock Exchange (NSE) via the corporate disclosure mechanism on 24 June 2026. The document was filed as an NCLT proceeding notification, indicating that the company has initiated or is proceeding with a corporate restructuring or amalgamation under Part VIII of the Companies Act, 2013. The specific structure, parties, consideration, and regulatory milestones remain to be disclosed in full scheme documents and NCLT petitions.
Why it mattersA Scheme of Arrangement signals potential intra-group restructuring, subsidiary merger, or debt/equity reorganisation - triggering NCLT approval as a gating item and requiring careful review of minority shareholder protections and creditor dissent thresholds under ss. 230–232 CA.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Archives – Apollo Hospitals Corporate Disclosure · official
- Apollo Hospitals Enterprise Limited – Investor Relations / BSE Listing · official
- BSE - Announcements / Corporate Actions · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026